Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR –TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations

ConclusionSecond-line cytotoxic drug chemotherapy after first-line EGFR –TKI treatment among elderly patients with NSCLC harboring sensitiveEGFR mutations was effective and safe and showed equivalent outcomes to first-line cytotoxic drug chemotherapy.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research